Page 83 - 《中国药房》2023年4期
P. 83

·药物与临床·


          个体化肠外营养支持对比预混肠外营养配方对急性肾损伤患者

          肝功能的影响
                               Δ

                                  1
                          2
          张 瑞 ,郑 军 ,杨 浩 ,金小越 (1.新疆医科大学第六附属医院药学部,乌鲁木齐 830002;2.新疆医科大
                 1*
                                          1 #
          学第六附属医院重症医学科,乌鲁木齐  830002)
          中图分类号  R979.9;R459.3      文献标志码  A      文章编号  1001-0408(2023)04-0457-04
          DOI  10.6039/j.issn.1001-0408.2023.04.14

          摘  要  目的  比较个体化肠外营养支持对比预混肠外营养配方对急性肾损伤(AKI)患者肝功能的影响。方法  选择 2021 年 1
          月-2022年3月我院重症医学科收治的97例AKI患者,按随机数字表法分为商业预混多腔袋(MCB)组(48例)和个体化全合-营
          养液(COM)组(49例)。两组患者及时给予纠正可逆性病因的常规治疗,待液体复苏成功或小剂量血管活性药物血流动力学稳定
          后48 h内开始肠外营养支持治疗。MCB组患者给予脂肪乳氨基酸(17)葡萄糖(11%)注射液1袋,静脉输注,每日1次。COM组患
          者给予中/长链脂肪乳注射液(C8~24Ve)0.5~0.8 g/kg+复方氨基酸18AA-Ⅶ 1.0~1.2 g/kg+葡萄糖注射液1.5~2.5 g/kg+注射用水
          溶性维生素1支+脂溶性维生素注射液(Ⅱ)10 mL+多种微量元素注射液(Ⅱ)10 mL+个体化补充氯化钠、氯化钾,糖脂比5∶5、热氮
          比 100∶1。两组患者疗程均为 7 d。观察两组患者治疗前后的肝功能异常占比、肝功能指标[丙氨酸转氨酶(ALT)、总胆红素
         (TBIL)、天冬氨酸转氨酶(AST)]、白蛋白(ALB)、白细胞介素6(IL-6)及C反应蛋白(CRP)水平。结果  治疗后,MCB组患者的肝
          功能异常占比、ALT、AST、CRP水平均显著高于同组治疗前,且MCB组患者的肝功能异常占比、ALT、CRP水平均显著高于COM
          组(P<0.05);COM组患者治疗前后肝功能异常占比、ALT、AST、TBIL、CRP水平比较,差异均无统计学意义(P>0.05)。结论  个
          体化肠外营养支持治疗可减少AKI患者肝损伤的发生,改善患者的营养状况。
          关键词  急性肾损伤;肝损伤;个体化肠外营养;肝功能

          Effects  of  individualized  parenteral  nutrition  versus  pre-mixed  parenteral  nutrition  on  liver  function  of

          patients with acute kidney injury
                                                          1
                     1
          ZHANG Rui ,ZHENG Jun ,YANG Hao ,JIN Xiaoyue(1.  Dept.  of  Pharmacy,  the  Sixth Affiliated  Hospital  of
                                              1
                                  2
          Xinjiang  Medical  University,  Urumqi  830002,  China;2.  Intensive  Care  Unit,  the  Sixth  Affiliated  Hospital  of
          Xinjiang Medical University, Urumqi 830002, China)
          ABSTRACT   OBJECTIVE  To  compare  the  effects  of  individualized  parenteral  nutrition  versus  pre-mixed  parenteral  nutrition  on
          liver  function  of  patients  with  acute  kidney  injury (AKI).  METHODS  Totally  97  AKI  patients  in  the  intensive  care  unit  of  our
          hospital  from  January  2021  to  March  2022  were  collected  and  randomly  divided  into  pre-mixed  multi-chamber  bag (MCB)  group
         (48 cases) and compounded parenteral nutrition (COM) group (49 cases). The patients in both groups were given routine treatment
          to  correct  the  reversible  cause  in  time,  and  parenteral  nutrition  support  treatment  was  started  within  48  hours  after  the  fluid
          resuscitation was successful or the hemodynamics of low-dose vasoactive drugs were stable. MCB group was given one bag of Fat
          emulsion amino acid (17) glucose (11%) injection, intravenous infusion, once a day; COM group was given Medium/long chain
          Fat  emulsion  injection (C8-24Ve)  0.5-0.8  g/kg+Compound  amino  acid  18AA-Ⅶ  1.0-1.2  g/kg+Glucose  injection  1.5-2.5  g/kg+one
          Water  soluble  vitamin  injection+Fat-soluble  vitamin  injection (Ⅱ)  10  mL+Multiple  trace  element  injection (Ⅱ)  10  mL+
                                                             individualized  supplement  of  sodium  chloride  and  potassium
             Δ 基金项目 国家自然科学基金资助项目(No.81760749);新疆医
          科大学第六临床医学院(第六附属医院)2020 年科研专项基金资助                   chloride, with a ratio of glucose to lipid of 5∶5 and a ratio of
          项目                                                 heat to nitrogen of 100∶1. The treatment course of both groups
             *第一作者 主管药师,硕士。研究方向:临床药学。电话:0991-                lasted  for  7  days.  The  percentage  of  abnormal  liver  function,
          2615177。E-mail:zhangrui9346@163.com
                                                             the  levels  of  liver  function  indexes  [alanine  aminotransferase
             # 通信作者 主任药师,硕士。研究方向:临床药学、民族药药理
          学。电话:0991-2615177。E-mail:jinxiaoyue0112@163.com   (ALT) ,  total  bilirubin  (TBIL) ,  aspartate  transaminase


          中国药房  2023年第34卷第4期                                                 China Pharmacy  2023 Vol. 34  No. 4    · 457 ·
   78   79   80   81   82   83   84   85   86   87   88